In addition, IFN-γ has been associated with maintaining the growth of invasive ductal carcinoma of the breast, so reducing its levels in this particular case would be favorable, but not at the systemic level because the secreted CTL could destroy tumor cells [37]. This evidence concerns the gene IFNG and invasive ductal breast carcinoma.